SEARCH:
Print

Clinical Trials

Bavarian Nordic and its partners conduct clinical studies of its vaccine candidates to evaluate their safety and efficacy.

Clinical studies that are actively enrolling patients or are planned are detailed below.

PROSTVAC

Phase 2 Study of Adjuvant PROSTVAC in Subjects at High Risk for Relapse After Radical Prostatectomy
Location: USA
Read more: NCT02772562
Phase 1/2 Study of PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer
Location: USA
Read more: NCT02933255
Phase 2 Trial of PROSTVAC and Ipilimumab as Monotherapy or in Combination for Men With Localized Prostate Cancer Undergoing Radical Prostatectomy
Location: USA
Read more: NCT02506114
Phase 2 Randomized, Placebo-Controlled Trial of PROSTVAC in Patients With Clinically Localized Prostate Cancer Undergoing Active Surveillance
Location: USA
Read more: NCT02326805
Phase 2 Study of PROSTVAC in Patients With Biochemical Recurrent Prostate Cancer
Location: USA
Read more: NCT02649439
Phase 2 Study of PROSTVAC and Docetaxel for Metastatic Castration Sensitive Prostate Cancer
Location: USA
Read more: NCT02649855

CV301

Phase 1/2 Trial of CV301 in Combination With Anti-PD-1 Therapy Versus Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
Location: USA
Read more: NCT02840994
Phase 2 Study Combining CV301 (PANVAC) with Bacillus Calmette-Guerin (BCG) vs. BCG Alone in High Grade Non-Muscle Invasive Bladder Cancer
Location: USA
Read more: NCT02015104

MVA-BN Filo

Phase 2 study evaluating the safety, tolerability and immunogenicity of three prime-boost regimens of MVA-BN Filo and Ad26.ZEBOV in healthy adult participants, including elderly, HIV-infected, and healthy children in three age strata.
Locations: Uganda, Kenya
Read more: NCT02564523
Phase 3 study evaluating the safety and immunogenicity of Ebola candidate vaccines Ad26.ZEBOV and MVA-BN-Filo (EBOVAC-Salone)
Location: Sierra Leone
Read more: NCT02509494